| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $428.9M | — | +6.6% |
| Cost of Revenue | $49.2M | — | -0.4% |
| R&D Expense | $27.5M | — | +5.8% |
| SG&A Expense | $58.6M | — | +5.2% |
| Operating Income | $293.6M | — | +8.3% |
| Interest Expense | $18.9M | — | -6.9% |
| Pre-tax Income | $279.4M | — | +8.1% |
| Income Tax | $64.9M | — | +9.8% |
| Net Income | $214.5M | — | +7.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $476.7M | +54.8% | -17.2% |
| Short-term Investments | $79.7M | -70.8% | +9.0% |
| Accounts Receivable | $11.3M | +46.8% | — |
| Current Assets | $626.0M | -4.1% | -12.3% |
| Total Assets | $1.30B | -2.2% | -10.4% |
| Current Liabilities | $1.36B | +1.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $272.4M | — | -6.5% |
| Capital Expenditures | $7.2M | — | +24.1% |
| Investing Cash Flow | $187.2M | — | -41.1% |
| Financing Cash Flow | -$291.1M | — | -21.3% |
| Free Cash Flow | $265.2M | — | -7.1% |
| +5.3% |
| Total Liabilities | $3.51B | +0.9% | +2.5% |
| Stockholders' Equity | -$2.21B | -2.7% | -12.0% |